Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
Introduction: In clinical practice, warfarin is often combined with Compound Danshen dripping pill (CDDP) for the treatment of cardiovascular diseases. However, warfarin has a narrow therapeutic index, wide interindividual variability (genetic and non-genetic factors), and is susceptible to drug-dru...
Saved in:
Main Authors: | Xixi Chen (Author), Xurui Zuo (Author), Yingqiang Zhao (Author), Yuhong Huang (Author), Chunxiao Lv (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proangiogenesis effects of compound danshen dripping pills in zebrafish
by: Yang-Xi Hu, et al.
Published: (2022) -
Soluble epoxide hydrolase in the human placenta throughout gestation
by: Tai-Ho Hung, et al.
Published: (2019) -
Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
Published: (2020) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019) -
The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation
by: Chunxiao Lv, et al.
Published: (2017)